Abstract
Epilepsy is a neural network disorder caused by uncontrolled neuronal hyperexcitability induced by an imbalance between excitatory and inhibitory networks. Abnormal synaptogenesis plays a vital role in the formation of overexcited networks. Recent evidence has confirmed that thrombospondin-1 (TSP-1), mainly secreted by astrocytes, is a critical cytokine that regulates synaptogenesis during epileptogenesis. Furthermore, numerous studies have reported that TSP-1 is also involved in other processes, such as angiogenesis, neuroinflammation, and regulation of Ca2+ homeostasis, which are closely associated with the occurrence and development of epilepsy. In this review, we summarize the potential contributions of TSP-1 to epilepsy development.
Similar content being viewed by others
References
Aronica E, Mühlebner A. Neuropathology of epilepsy. Handb Clin Neurol 2017, 145: 193–216.
Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019, 393: 689–701.
Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006, 367: 1087–1100.
Tian N, Boring M, Kobau R, Zack MM, Croft JB. Active epilepsy and seizure control in adults - United States, 2013 and 2015. MMWR Morb Mortal Wkly Rep 2018, 67: 437–442.
Mendus D, Rankin-Gee EK, Mustapha M, Porter BE. Increased sensitivity to kindling in mice lacking TSP1. Neuroscience 2015, 305: 302–308.
Goldberg EM, Coulter DA. Mechanisms of epileptogenesis: A convergence on neural circuit dysfunction. Nat Rev Neurosci 2013, 14: 337–349.
Codazzi F, Pelizzoni I, Zacchetti D, Grohovaz F. Iron entry in neurons and astrocytes: A link with synaptic activity. Front Mol Neurosci 2015, 8: 18.
Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. Control of synapse number by glia. Science 2001, 291: 657–661.
Foulsham W, Dohlman TH, Mittal SK, Taketani Y, Singh RB, Masli S. Thrombospondin-1 in ocular surface health and disease. Ocul Surf 2019, 17: 374–383.
Cheng C, Lau SKM, Doering LC. Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model. Mol Brain 2016, 9: 74.
Christopherson KS, Ullian EM, Stokes CCA, Mullowney CE, Hell JW, Agah A, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120: 421–433.
Baldwin KT, Eroglu C. Molecular mechanisms of astrocyte-induced synaptogenesis. Curr Opin Neurobiol 2017, 45: 113–120.
Hennekinne L, Colasse S, Triller A, Renner M. Differential control of thrombospondin over synaptic glycine and AMPA receptors in spinal cord neurons. J Neurosci 2013, 33: 11432–11439.
Sun H, Ma L, Zhang Y, Pan X, Wang C, Zhang J, et al. A purinergic P2 receptor family-mediated increase in thrombospondin-1 bolsters synaptic density and epileptic seizure activity in the amygdala-kindling rat model. Front Cell Neurosci 2018, 12: 302.
Zhang Y, Zhang M, Zhu W, Pan X, Wang Q, Gao X, et al. Role of elevated thrombospondin-1 in kainic acid-induced status epilepticus. Neurosci Bull 2020, 36: 263–276.
Torres MD, Garcia O, Tang C, Busciglio J. Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome. Free Radic Biol Med 2018, 114: 10–14.
Risher WC, Eroglu C. Thrombospondins as key regulators of synaptogenesis in the central nervous system. Matrix Biol 2012, 31: 170–177.
Zhang Y, Zhu W, Yu H, Yu J, Zhang M, Pan X, et al. P2Y4/TSP-1/TGF-β1/pSmad2/3 pathway contributes to acute generalized seizures induced by kainic acid. Brain Res Bull 2019, 149: 106–119.
Nishitsuji K, Ikezaki M, Manabe S, Uchimura K, Ito Y, Ihara Y. Thrombospondin type 1 repeat-derived C-mannosylated peptide attenuates synaptogenesis of cortical neurons induced by primary astrocytes via TGF-Β. Glycoconj J 2022, 39: 701–710.
Henshall DC, Simon RP. Epilepsy and apoptosis pathways. J Cereb Blood Flow Metab 2005, 25: 1557–1572.
Pototskiy E, Dellinger JR, Bumgarner S, Patel J, Sherrerd-Smith W, Musto AE. Brain injuries can set up an epileptogenic neuronal network. Neurosci Biobehav Rev 2021, 129: 351–366.
Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation 2018, 15: 144.
Geronzi U, Lotti F, Grosso S. Oxidative stress in epilepsy. Expert Rev Neurother 2018, 18: 427–434.
Badawy RAB, Freestone DR, Lai A, Cook MJ. Epilepsy: Ever-changing states of cortical excitability. Neuroscience 2012, 222: 89–99.
Huang T, Sun L, Yuan X, Qiu H. Thrombospondin-1 is a multifaceted player in tumor progression. Oncotarget 2017, 8: 84546–84558.
Schöllhorn L, Bock F, Cursiefen C. Thrombospondin-1 as a regulator of corneal inflammation and lymphangiogenesis: Effects on dry eye disease and corneal graft immunology. J Ocul Pharmacol Ther 2015, 31: 376–385.
Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A 1971, 68: 240–243.
Kayser H, Mann K, Machaidze G, Nimtz M, Ringler P, Müller SA, et al. Isolation, characterisation and molecular imaging of a high-molecular-weight insect biliprotein, a member of the hexameric arylphorin protein family. J Mol Biol 2009, 389: 74–89.
Liu YS, Yang M. The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis. Hematology 2006, 11: 53–56.
Adams JC. Thrombospondin-1. Int J Biochem Cell Biol 1997, 29: 861–865.
Carlson CB, Lawler J, Mosher DF. Structures of thrombospondins. Cell Mol Life Sci 2008, 65: 672–686.
Adams JC, Lawler J. The thrombospondins. Cold Spring Harb Perspect Biol 2011, 3: a009712.
Zhang K, Li M, Yin L, Fu G, Liu Z. Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review). Int J Mol Med 2020, 45: 1275–1293.
Duquette M, Nadler M, Okuhara D, Thompson J, Shuttleworth T, Lawler J. Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activity. Matrix Biol 2014, 37: 15–24.
Sims JN, Lawler J. Thrombospondin-1-based antiangiogenic therapy. J Ocul Pharmacol Ther 2015, 31: 366–370.
Kaur S, Roberts DD. Why do humans need thrombospondin-1? J Cell Commun Signal 2023, 17: 485–493.
Zhang X, Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc Res 2007, 74: 90–99.
Resovi A, Pinessi D, Chiorino G, Taraboletti G. Current understanding of the thrombospondin-1 interactome. Matrix Biol 2014, 37: 83–91.
Lindberg FP, Gresham HD, Schwarz E, Brown EJ. Molecular cloning of integrin-associated protein: An immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol 1993, 123: 485–496.
Lehrman EK, Wilton DK, Litvina EY, Welsh CA, Chang ST, Frouin A, et al. CD47 protects synapses from excess microglia-mediated pruning during development. Neuron 2018, 100: 120-134.e6.
McDonald JF, Dimitry JM, Frazier WA. An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs. Biochemistry 2003, 42: 10001–10011.
Gheibihayat SM, Cabezas R, Nikiforov NG, Jamialahmadi T, Johnston TP, Sahebkar A. CD47 in the brain and neurodegeneration: An update on the role in neuroinflammatory pathways. Molecules 2021, 26: 3943.
Tanase C, Enciu AM, Codrici E, Popescu ID, Dudau M, Dobri AM, et al. Fatty acids, CD36, thrombospondin-1, and CD47 in glioblastoma: Together and/or separately? Int J Mol Sci 2022, 23: 604.
Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest 2001, 107: 45–52.
Kaur S, Bronson SM, Pal-Nath D, Miller TW, Soto-Pantoja DR, Roberts DD. Functions of thrombospondin-1 in the tumor microenvironment. Int J Mol Sci 2021, 22: 4570.
Bongrazio M, Da Silva-Azevedo L, Bergmann EC, Baum O, Hinz B, Pries AR, et al. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Int J Immunopathol Pharmacol 2006, 19: 35–48.
Ortiz-Masià D, Díez I, Calatayud S, Hernández C, Cosín-Roger J, Hinojosa J, et al. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process. PLoS One 2012, 7: e48535.
Zong P, Feng J, Li CX, Jellison ER, Yue Z, Miller B, et al. Activation of endothelial TRPM2 exacerbates blood-brain barrier degradation in ischemic stroke. Cardiovasc Res 2024, 120: 188–202.
Ma Y, Halade GV, Lindsey ML. Extracellular matrix and fibroblast communication following myocardial infarction. J Cardiovasc Transl Res 2012, 5: 848–857.
Wang X, Chen W, Liu W, Wu J, Shao Y, Zhang X. The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat. J Clin Neurosci 2009, 16: 818–821.
Xu J, Xiao N, Xia J. Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat Neurosci 2010, 13: 22–24.
Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011, 7: 1056–1067.
Greenaway J, Lawler J, Moorehead R, Bornstein P, Lamarre J, Petrik J. Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol 2007, 210: 807–818.
Diaz A, Yepes M. Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain. Neural Regen Res 2018, 13: 232–233.
Sizova O, John LS, Ma Q, Molldrem JJ. Multi-faceted role of LRP1 in the immune system. Front Immunol. 2023, 14: 1166189.
Eroglu C, Allen NJ, Susman MW, O’Rourke NA, Park CY, Ozkan E, et al. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009, 139: 380–392.
Eroglu C, Barres BA. Regulation of synaptic connectivity by glia. Nature 2010, 468: 223–231.
Wang DD, Bordey A. The astrocyte odyssey. Prog Neurobiol 2008, 86: 342–367.
Oyasu M, Kuroda S, Nakashita M, Fujimiya M, Kikkawa U, Saito N. Immunocytochemical localization of a neuron-specific thrombospondin-1-like protein, NELL2: Light and electron microscopic studies in the rat brain. Brain Res Mol Brain Res 2000, 76: 151–160.
Danjo Y, Shigetomi E, Hirayama YJ, Kobayashi K, Ishikawa T, Fukazawa Y, et al. Transient astrocytic mGluR5 expression drives synaptic plasticity and subsequent chronic pain in mice. J Exp Med 2022, 219: e20210989.
Tagnaouti N, Loebrich S, Heisler F, Pechmann Y, Fehr S, De Arcangelis A, et al. Neuronal expression of muskelin in the rodent central nervous system. BMC Neurosci 2007, 8: 28.
Scott-Drew S, ffrench-Constant C. Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system. J Neurosci Res 1997, 50: 202–214.
Cheng C, Yu Z, Zhao S, Liao Z, Xing C, Jiang Y, et al. Thrombospondin-1 gene deficiency worsens the neurological outcomes of traumatic brain injury in mice. Int J Med Sci 2017, 14: 927–936.
Qin C, Wang K, Zhang L, Bai L. Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality. Animal Model Exp Med 2022, 5: 15–26.
Sher AA, Glover KKM, Coombs KM. Zika virus infection disrupts astrocytic proteins involved in synapse control and axon guidance. Front Microbiol 2019, 10: 596.
Garcia O, Torres M, Helguera P, Coskun P, Busciglio J. A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down’s syndrome. PLoS One 2010, 5: e14200.
Wang B, Zou L, Li M, Zhou L. Astrocyte: A foe or a friend in intellectual disability-related diseases. Front Synaptic Neurosci 2022, 14: 877928.
Yu K, Ge J, Summers JB, Li F, Liu X, Ma P, et al. TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival. PLoS One 2008, 3: e2470.
Diniz LP, Almeida JC, Tortelli V, Vargas Lopes C, Setti-Perdigão P, Stipursky J, et al. Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons. J Biol Chem 2012, 287: 41432–41445.
Tran MD, Furones-Alonso O, Sanchez-Molano J, Bramlett HM. Trauma-induced expression of astrocytic thrombospondin-1 is regulated by P2 receptors coupled to protein kinase cascades. Neuroreport 2012, 23: 721–726.
Lin Z, Gu Y, Zhou R, Wang M, Guo Y, Chen Y, et al. Serum exosomal proteins F9 and TSP-1 as potential diagnostic biomarkers for newly diagnosed epilepsy. Front Neurosci 2020, 14: 737.
Wang B, Guo W, Huang Y. Thrombospondins and synaptogenesis. Neural Regen Res 2012, 7: 1737–1743.
Nagai J, Rajbhandari AK, Gangwani MR, Hachisuka A, Coppola G, Masmanidis SC, et al. Hyperactivity with disrupted attention by activation of an astrocyte synaptogenic cue. Cell 2019, 177: 1280-1292.e20.
Min-DeBartolo J, Schlerman F, Akare S, Wang J, McMahon J, Zhan Y, et al. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). PLoS One 2019, 14: e0226854.
Ungefroren H, Gieseler F, Kaufmann R, Settmacher U, Lehnert H, Rauch BH. Signaling crosstalk of TGF-β/ALK5 and PAR2/PAR1: A complex regulatory network controlling fibrosis and cancer. Int J Mol Sci 2018, 19: 1568.
Kisseleva EP, Krylov AV, Stepanova OI, Lioudyno VI. Transplantable subcutaneous hepatoma 22a affects functional activity of resident tissue macrophages in periphery. Int J Cell Biol 2011, 2011: 793034.
Hisaoka-Nakashima K, Yokoe T, Watanabe S, Nakamura Y, Kajitani N, Okada-Tsuchioka M, et al. Lysophosphatidic acid induces thrombospondin-1 production in primary cultured rat cortical astrocytes. J Neurochem 2021, 158: 849–864.
Bussolati B, Assenzio B, Deregibus MC, Camussi G. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway. J Mol Med 2006, 84: 852–863.
Pacurari M, Mitra A, Turner T. Idiopathic pulmonary comorbidities and mechanisms. Int J Inflam 2021, 2021: 3963659.
Planas-Fontánez TM, Sainato DM, Sharma I, Dreyfus CF. Roles of astrocytes in response to aging, Alzheimer’s disease and multiple sclerosis. Brain Res 2021, 1764: 147464.
Rama Rao KV, Kielian T. Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation. Clin Exp Neuroimmunol 2015, 6: 245–263.
Jo WS, Mizukami Y, Duerr EM, Zukerberg LR, Chung DC. Wnt signaling can repress thrombospondin-1 expression in colonic tumorigenesis. Cancer Biol Ther 2005, 4: 1361–1366.
Fairaq A, Goc A, Artham S, Sabbineni H, Somanath PR. TNFα induces inflammatory stress response in microvascular endothelial cells via Akt- and P38 MAP kinase-mediated thrombospondin-1 expression. Mol Cell Biochem 2015, 406: 227–236.
Orozco-Morales M, Avilés-Salas A, Hernández-Pedro N, Catalán R, Cruz-Rico G, Colín-González AL, et al. Clinicopathological and prognostic significance of CD47 expression in lung neuroendocrine tumors. J Immunol Res 2021, 2021: 6632249.
Giehl K, Graness A, Goppelt-Struebe M. The small GTPase Rac-1 is a regulator of mesangial cell morphology and thrombospondin-1 expression. Am J Physiol Renal Physiol 2008, 294: F407–F413.
Chodobski A, Zink BJ, Szmydynger-Chodobska J. Blood–brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2011, 2: 492–516.
Yurdagul A Jr, Finney AC, Woolard MD, Orr AW. The arterial microenvironment: The where and why of atherosclerosis. Biochem J 2016, 473: 1281–1295.
Cho J, Huh Y. Astrocytic calcium dynamics along the pain pathway. Front Cell Neurosci 2020, 14: 594216.
Bogáti R, Katona É, Shemirani AH, Balogh E, Bárdos H, Jeney V, et al. The effect of activated FXIII, a transglutaminase, on vascular smooth muscle cells. Int J Mol Sci 2022, 23: 5845.
Gao Z, Hu H. Star-like cells spark behavioural hyperactivity in mice. Nature 2019, 571: 43–44.
Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999, 274: 13586–13593.
Zhao Y, Pu D, Sun Y, Chen J, Luo C, Wang M, et al. High glucose-induced defective thrombospondin-1 release from astrocytes via TLR9 activation contributes to the synaptic protein loss. Exp Cell Res 2018, 363: 171–178.
Takeuchi K, Ariyoshi Y, Shimizu A, Okumura Y, Cara-Fuentes G, Garcia GE, et al. Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation. Xenotransplantation 2021, 28: e12708.
Murphy-Ullrich JE. Thrombospondin-1 signaling through the calreticulin/LDL receptor related protein 1 axis: Functions and possible roles in glaucoma. Front Cell Dev Biol 2022, 10: 898772.
Maeda N, Maenaka K. The roles of matricellular proteins in oncogenic virus-induced cancers and their potential utilities as therapeutic targets. Int J Mol Sci 2017, 18: 2198.
Jeong JK, Kim JG, Kim HR, Lee TH, Park JW, Lee BJ. A role of central NELL2 in the regulation of feeding behavior in rats. Mol Cells 2017, 40: 186–194.
Heller JP, Rusakov DA. Morphological plasticity of astroglia: Understanding synaptic microenvironment. Glia 2015, 63: 2133–2151.
Pascual MR. Temporal lobe epilepsy: Clinical semiology and neurophysiological studies. Semin Ultrasound CT MR 2007, 28: 416–423.
Samanta D. Epilepsy in Angelman syndrome: A scoping review. Brain Dev 2021, 43: 32–44.
Wang YH, Huang TL, Chen X, Yu SX, Li W, Chen T, et al. Glioma-derived TSP2 promotes excitatory synapse formation and results in hyperexcitability in the peritumoral cortex of glioma. J Neuropathol Exp Neurol 2021, 80: 137–149.
Sutula TP, Dudek FE. Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: An emergent property of a complex system. Prog Brain Res 2007, 163: 541–563.
Franck JE, Pokorny J, Kunkel DD, Schwartzkroin PA. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia 1995, 36: 543–558.
Santhakumar V, Aradi I, Soltesz I. Role of mossy fiber sprouting and mossy cell loss in hyperexcitability: A network model of the dentate gyrus incorporating cell types and axonal topography. J Neurophysiol 2005, 93: 437–453.
Zhang W, Thamattoor AK, LeRoy C, Buckmaster PS. Surviving mossy cells enlarge and receive more excitatory synaptic input in a mouse model of temporal lobe epilepsy. Hippocampus 2015, 25: 594–604.
Puhahn-Schmeiser B, Leicht K, Gessler F, Freiman TM. Aberrant hippocampal mossy fibers in temporal lobe epilepsy target excitatory and inhibitory neurons. Epilepsia 2021, 62: 2539–2550.
Ishibashi M, Egawa K, Fukuda A. Diverse actions of astrocytes in GABAergic signaling. Int J Mol Sci 2019, 20: 2964.
Fujimura M, Usuki F, Nakamura A. Methylmercury induces hyperalgesia/allodynia through spinal cord dorsal horn neuronal activation and subsequent somatosensory cortical circuit formation in rats. Arch Toxicol 2021, 95: 2151–2162.
Wu Q, Finley SD. Mathematical model predicts effective strategies to inhibit VEGF-eNOS signaling. J Clin Med 2020, 9: 1255.
Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002, 6: 1–12.
van Eekelen M, Sasportas LS, Kasmieh R, Yip S, Figueiredo JL, Louis DN, et al. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene 2010, 29: 3185–3195.
Jeanne A, Sick E, Devy J, Floquet N, Belloy N, Theret L, et al. Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget 2015, 6: 17981–18000.
Fernando KHN, Yang HW, Jiang Y, Jeon YJ, Ryu B. Ishige okamurae extract and its constituent ishophloroglucin A attenuated in vitro and in vivo high glucose-induced angiogenesis. Int J Mol Sci 2019, 20: 5542.
Walewska E, Wołodko K, Skarzynski D, Ferreira-Dias G, Galvão A. The interaction between nodal, hypoxia-inducible factor 1 alpha, and thrombospondin 1 promotes luteolysis in equine corpus luteum. Front Endocrinol 2019, 10: 667.
Miyata Y, Sakai H. Thrombospondin-1 in urological cancer: Pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci 2013, 14: 12249–12272.
Zhang J, Yang W, Zhao D, Han Y, Liu B, Zhao H, et al. Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density. Oncol Lett 2014, 7: 95–100.
Gustavsson H, Tesan T, Jennbacken K, Kuno K, Damber JE, Welén K. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. BMC Cancer 2010, 10: 288.
Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman VL, Croul SE, et al. Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res 2007, 100: 1308–1316.
Yang AL, Zhou HJ, Lin Y, Luo JK, Cui HJ, Tang T, et al. Thrombin promotes the expression of thrombospondin-1 and-2 in a rat model of intracerebral hemorrhage. J Neurol Sci 2012, 323: 141–146.
Feng N, Wang Z, Zhang Z, He X, Wang C, Zhang L. MiR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1. Neurosci Lett 2015, 591: 1–7.
Soltani A, Walters EH, Reid DW, Shukla SD, Nowrin K, Ward C, et al. Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD. Int J Chron Obstruct Pulmon Dis 2016, 11: 2359–2367.
Uchida H, Kuroki M, Shitama T, Hayashi H, Kuroki M. Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cells. Curr Eye Res 2008, 33: 199–203.
Morandi V. The N-terminal domain of thrombospondin-1: A key for the dual effect of TSP-1 in angiogenesis and cancer progression? Sci World J 2009, 9: 133–136.
Prangsaengtong O, Park JY, Inujima A, Igarashi Y, Shibahara N, Koizumi K. Enhancement of lymphangiogenesis in vitro via the regulations of HIF-1α expression and nuclear translocation by deoxyshikonin. Evid Based Complement Alternat Med 2013, 2013: 148297.
Ghorbanzadeh V, Pourheydar B, Dariushnejad H, Ghalibafsabbaghi A, Chodari L. Curcumin improves angiogenesis in the heart of aged rats: Involvement of TSP1/NF-κB/VEGF-A signaling. Microvasc Res 2022, 139: 104258.
Chong HC, Tan CK, Huang RL, Tan NS. Matricellular proteins: A sticky affair with cancers. J Oncol 2012, 2012: 351089.
Li S, Dong J, Ta G, Liu Y, Cui J, Li X, et al. Xuan Bi Tong yu Fang promotes angiogenesis via VEGF-Notch1/Dll4 pathway in myocardial ischemic rats. Evid Based Complement Alternat Med 2020, 2020: 5041629.
Baulac M. MTLE with hippocampal sclerosis in adult as a syndrome. Rev Neurol 2015, 171: 259–266.
Morin-Brureau M, Rigau V, Lerner-Natoli M. Why and how to target angiogenesis in focal epilepsies. Epilepsia 2012, 53: 64–68.
Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood–brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130: 1942–1956.
Castro-Torres RD, Ureña-Guerrero ME, Morales-Chacón LM, Lorigados-Pedre L, Estupiñan-Díaz B, Rocha L, et al. New aspects of VEGF, GABA, and glutamate signaling in the neocortex of human temporal lobe pharmacoresistant epilepsy revealed by RT-qPCR arrays. J Mol Neurosci 2020, 70: 916–929.
Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol 2012, 33: 116–125.
Castañeda-Cabral JL, Colunga-Durán A, Ureña-Guerrero ME, Beas-Zárate C, Nuñez-Lumbreras MLA, Orozco-Suárez S, et al. Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy. Microvasc Res 2020, 132: 104059.
Rempe RG, Hartz AMS, Soldner ELB, Sokola BS, Alluri SR, Abner EL, et al. Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy. J Neurosci 2018, 38: 4301–4315.
Löscher W, Friedman A. Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: A cause, consequence, or both? Int J Mol Sci 2020, 21: 591.
Han H, Mann A, Ekstein D, Eyal S. Breaking bad: The structure and function of the blood-brain barrier in epilepsy. AAPS J 2017, 19: 973–988.
Häussinger D, Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care 2010, 13: 87–92.
Ning M, Sarracino DA, Kho AT, Guo S, Lee SR, Krastins B, et al. Proteomic temporal profile of human brain endothelium after oxidative stress. Stroke 2011, 42: 37–43.
Gao JB, Tang WD, Wang HX, Xu Y. Predictive value of thrombospondin-1 for outcomes in patients with acute ischemic stroke. Clin Chim Acta 2015, 450: 176–180.
Sun AY, Chen YM. Oxidative stress and neurodegenerative disorders. J Biomed Sci 1998, 5: 401–414.
Ruhela D, Bhopale VM, Kalakonda S, Thom SR. Astrocyte-derived microparticles initiate a neuroinflammatory cycle due to carbon monoxide poisoning. Brain Behav Immun Health 2021, 18: 100398.
Kang S, Byun J, Son SM, Mook-Jung I. Thrombospondin-1 protects against Aβ-induced mitochondrial fragmentation and dysfunction in hippocampal cells. Cell Death Discov 2018, 4: 31.
Waldbaum S, Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 2010, 88: 23–45.
Frantseva MV, Velazquez JL, Hwang PA, Carlen PL. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur J Neurosci 2000, 12: 1431–1439.
Yang N, Guan QW, Chen FH, Xia QX, Yin XX, Zhou HH, et al. Antioxidants targeting mitochondrial oxidative stress: Promising neuroprotectants for epilepsy. Oxid Med Cell Longev 2020, 2020: 6687185.
Puttachary S, Sharma S, Stark S, Thippeswamy T. Seizure-induced oxidative stress in temporal lobe epilepsy. Biomed Res Int 2015, 2015: 745613.
Chowdhury AR, Zielonka J, Kalyanaraman B, Hartley RC, Murphy MP, Avadhani NG. Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon. Redox Biol 2020, 36: 101606.
Souza MA, Mota BC, Gerbatin RR, Rodrigues FS, Castro M, Fighera MR, et al. Antioxidant activity elicited by low dose of caffeine attenuates pentylenetetrazol-induced seizures and oxidative damage in rats. Neurochem Int 2013, 62: 821–830.
Rowley S, Liang LP, Fulton R, Shimizu T, Day B, Patel M. Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy. Neurobiol Dis 2015, 75: 151–158.
Shekh-Ahmad T, Lieb A, Kovac S, Gola L, Christian Wigley W, Abramov AY, et al. Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy. Redox Biol 2019, 26: 101278.
Cenini G, Lloret A, Cascella R. Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid Med Cell Longev 2019, 2019: 2105607.
Mittal R, Gonzalez-Gomez I, Prasadarao NV. Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis. J Immunol 2010, 185: 2998–3006.
Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996, 271: 21–24.
Bornstein P. Thrombospondins: Structure and regulation of expression. FASEB J 1992, 6: 3290–3299.
Thom SR, Bhopale VM, Bhat AR, Arya AK, Ruhela D, Qiao G, et al. Neuroinflammation with increased glymphatic flow in a murine model of decompression sickness. J Neurophysiol 2023, 129: 662–671.
Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells. Blood 2005, 106: 658–667.
Li P, Marshall L, Oh G, Jakubowski JL, Groot D, He Y, et al. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms. Nat Commun 2019, 10: 2246.
Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006, 281: 26069–26080.
Gong L, Gu Y, Han X, Luan C, Liu C, Wang X, et al. Spatiotemporal dynamics of the molecular expression pattern and intercellular interactions in the glial scar response to spinal cord injury. Neurosci Bull 2023, 39: 213–244.
Huang L, Tang H, Sherchan P, Lenahan C, Boling W, Tang J, et al. The activation of phosphatidylserine/CD36/TGF-β1 pathway prior to surgical brain injury attenuates neuroinflammation in rats. Oxid Med Cell Longev 2020, 2020: 4921562.
Huang Y, Chen S, Luo Y, Han Z. Crosstalk between inflammation and the BBB in stroke. Curr Neuropharmacol 2020, 18: 1227–1236.
Gao L, Peng L, Sherchan P, Tang H, Liu Y, Xiao J, et al. Inhibition of lysophosphatidic acid receptor 1 relieves PMN recruitment in CNS via LPA1/TSP1/CXCR2 pathway and alleviates disruption on blood-brain barrier following intracerebral haemorrhage in mice. Fluids Barriers CNS 2023, 20: 33.
Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: Contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr 2017, 29: 1–16.
Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23: 8692–8700.
Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med J 2008, 49: 1–18.
Musto AE, Gjorstrup P, Bazan NG. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia 2011, 52: 1601–1608.
Musto AE, Rosencrans RF, Walker CP, Bhattacharjee S, Raulji CM, Belayev L, et al. Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Sci Rep 2016, 6: 30298.
Hong Z, Chen H, Hong H, Lin L, Wang Z. TSP-1 expression changes in diabetic rats with spinal cord injury. Neurol Res 2009, 31: 878–882.
Lin TN, Kim GM, Chen JJ, Cheung WM, He YY, Hsu CY. Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 2003, 34: 177–186.
Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol 2004, 36: 1115–1125.
Maikos JT, Shreiber DI. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J Neurotrauma 2007, 24: 492–507.
Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and spinal cord injury: Infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 2006, 6: 283–292.
Zhang L, Li L, Wang B, Qian DM, Song XM, Hu M. Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. Neuroreport 2013, 24: 526–535.
Jaber SM, Polster BM. An in vitro model yields ‘importin’ new insights into chronic traumatic encephalopathy: Damaged astrocytes stop ‘thrombospondin’ to the injury: An Editorial Highlight for ‘Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies’. J Neurochem 2017, 140: 531–535.
Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A. Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 2007, 178: 5930–5939.
Xie Y, Zhang J, Jin W, Tian R, Wang R. Role of Thrombospondin-1 in sepsis-induced myocardial injury. Mol Med Rep 2021, 24: 869.
Masli S, Sheibani N, Cursiefen C, Zieske J. Matricellular protein thrombospondins: Influence on ocular angiogenesis, wound healing and immuneregulation. Curr Eye Res 2014, 39: 759–774.
Roberts DD, Miller TW, Rogers NM, Yao M, Isenberg JS. The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol 2012, 31: 162–169.
Jayakumar AR, Tong XY, Shamaladevi N, Barcelona S, Gaidosh G, Agarwal A, et al. Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies. J Neurochem 2017, 140: 645–661.
Thom M, Zhou J, Martinian L, Sisodiya S. Quantitative post-mortem study of the hippocampus in chronic epilepsy: Seizures do not inevitably cause neuronal loss. Brain 2005, 128: 1344–1357.
Xu S, Sun Q, Fan J, Jiang Y, Yang W, Cui Y, et al. Role of astrocytes in post-traumatic epilepsy. Front Neurol 2019, 10: 1149.
McNamara JO, Huang YZ, Leonard AS. Molecular signaling mechanisms underlying epileptogenesis. Sci STKE 2006, 2006: re12.
Misenheimer TM, Mosher DF. Calcium ion binding to thrombospondin 1. J Biol Chem 1995, 270: 1729–1733.
Martin-Manso G, Galli S, Ridnour LA, Tsokos M, Wink DA, Roberts DD. Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. Cancer Res 2008, 68: 7090–7099.
Bissinger R, Petkova-Kirova P, Mykhailova O, Oldenborg PA, Novikova E, Donkor DA, et al. Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells. Cell Commun Signal 2020, 18: 155.
Bazzazi H, Isenberg JS, Popel AS. Inhibition of VEGFR2 activation and its downstream signaling to ERK1/2 and calcium by thrombospondin-1 (TSP1): In silico investigation. Front Physiol 2017, 8: 48.
Yang Y, Yang F, Yang F, Li CL, Wang Y, Li Z, et al. Gabapentinoid insensitivity after repeated administration is associated with down-regulation of the α(2)δ-1 subunit in rats with central post-stroke pain hypersensitivity. Neurosci Bull 2016, 32: 41–50.
Calzada MJ, Kuznetsova SA, Sipes JM, Rodrigues RG, Cashel JA, Annis DS, et al. Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1. Matrix Biol 2008, 27: 339–351.
Wang B, Li X, Yu N, Yang L, Nan C, Guo L, et al. Intracerebral hemorrhage alters α2δ1 and thrombospondin expression in rats. Exp Ther Med 2022, 23: 327.
Kim SK, Hayashi H, Ishikawa T, Shibata K, Shigetomi E, Shinozaki Y, et al. Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain. J Clin Invest 2016, 126: 1983–1997.
Risher WC, Kim N, Koh S, Choi JE, Mitev P, Spence EF, et al. Thrombospondin receptor α2δ-1 promotes synaptogenesis and spinogenesis via postsynaptic Rac1. J Cell Biol 2018, 217: 3747–3765.
Kadurin I, Ferron L, Rothwell SW, Meyer JO, Douglas LR, Bauer CS, et al. Proteolytic maturation of α2δ represents a checkpoint for activation and neuronal trafficking of latent calcium channels. Elife 2016, 5: e21143.
Acknowledgements
This review was supported by the Natural Science Foundation of Shandong Province (ZR2021MH034 and ZR2022MH059) and the National Natural Science Foundation of China (81573412). We’d like to thank Editage for English language editing.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cheng, Y., Zhai, Y., Yuan, Y. et al. The Contributions of Thrombospondin-1 to Epilepsy Formation. Neurosci. Bull. (2024). https://doi.org/10.1007/s12264-024-01194-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12264-024-01194-2